Overview:
On January 5, 2022 the Canadian Government amended the Food
and Drug Regulations to allow healthcare practitioners to
apply, on a case-by-case basis, to the Minister of Health (the
"Minister") for special access to a certain class of
"restricted drugs" including amphetamines, psilocybin and
lysergic acid diethylamide (LSD). Further, the January 5, 2022
amendments simplify the framework of regulation over all forms of
cocaine in Canada, thereby reducing complexity for stakeholders
applying to conduct activities with cocaine (e.g. research).
Restricted Drugs:
The Canadian Government regulates the possession, sale,
importation/exportation and use of controlled substances through
the Controlled Drugs and Substances Act and the Food
and Drugs Act. Between the Controlled Drugs and Substances
Act and the Food and Drugs Act, and their associated
regulations, controlled substances in Canada are sub-divided into
four categories of substances, consisting of